Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.

Cao, Heng; Huang, Jiao; Chang, Jie; Zhu, Yaqin; Liang, Junyu; Sun, Chuanyin; Lin, Jin

Cao, Heng; Huang, Jiao; Chang, Jie; Zhu, Yaqin; Liang, Junyu; Sun, Chuanyin; Lin, Jin.

Afiliación

Cao H; Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
Huang J; Department of Rheumatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
Chang J; Department of Rheumatology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
Zhu Y; Department of Traditional Chinese Medicine, Haining People Hospital, Haining 314499, Zhejiang Province, China.
Liang J; Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
Sun C; Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.
Lin J; Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.

J Transl Int Med ; 11(1): 46-56, 2023 Mar.

Article en En | MEDLINE | ID: mdl-37533847

Palabras clave

biomarker; idiopathic inflammatory myopathies; interstitial lung disease; prognosis; rapid progressive

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Transl Int Med Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google